Skip to main navigation
Skip to search
Skip to main content
RSU Home
Log in
Home
Research units
Profiles
Publications
Projects
Datasets
Activities
Research Infrastructure
Prizes
Press/Media
Search by expertise, name or affiliation
Hypoxia-induced molecular alterations and druggable targets in triple negative breast cancer cell lines - HipTNBC
Čakstiņa-Dzērve, Inese
(Project leader)
Mitre, Ingrīda
(Expert)
Rogoza, Oļesja
(Assistant (student))
Pirsko, Valdis
(Work package leader)
Institute of Microbiology and Virology
Overview
Fingerprint
Activities
(1)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Hypoxia
100%
Triple Negative Breast Cancer
100%
Breast Cancer Cell Line
100%
Messenger RNA
20%
Therapeutic Agent
10%
microRNA
10%
Tumour Heterogeneity
10%
Somatics
10%
Tumor Hypoxia
10%
DNA Methylation
10%
Protein Expression
10%
Cell Line
10%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Messenger RNA
100%
MicroRNA
50%
Tumor Hypoxia
50%
Protein Expression
50%
DNA Methylation
50%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
Hypoxia
100%
Neoplasm
18%
Messenger RNA
18%
microRNA
9%